Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited10.926915088825.7521
Domestic EquitiesDivi's Laboratories Limited8.67573100120.4467
Domestic EquitiesMax Healthcare Institute Limited6.119911575514.4231
Domestic EquitiesApollo Hospitals Enterprise Limited5.65511777513.3277
Domestic EquitiesCohance Lifesciences Limited4.659010997210.9802
Domestic EquitiesTorrent Pharmaceuticals Limited4.58232886110.7995
Domestic EquitiesAurobindo Pharma Limited3.6569756148.6185
Domestic EquitiesFortis Healthcare Limited3.5058963608.2624
Domestic EquitiesLupin Limited3.4553422138.1433
Domestic EquitiesAster DM Healthcare Limited3.19451244627.5287
Domestic EquitiesMankind Pharma Limited2.9655272246.9889
Domestic EquitiesWockhardt Limited2.7605390156.5058
Domestic EquitiesAlkem Laboratories Limited2.6584124536.2652
Domestic EquitiesAbbott India Limited2.467116905.8144
Domestic EquitiesNeuland Laboratories Limited2.242339795.2845
Domestic EquitiesSumitomo Chemical India Limited1.7109621604.0323
Domestic EquitiesHealthcare Global Enterprises Limited1.6632630133.9197
Domestic EquitiesVijaya Diagnostic Centre Limited1.5630342643.6836
Domestic EquitiesFDC Limited1.4427709333.4002
Domestic EquitiesGranules India Limited1.3821685913.2574
Domestic EquitiesLaurus Labs Limited1.3082352633.0832
Domestic EquitiesRainbow Childrens Medicare Limited1.3034201503.0717
Domestic EquitiesSagility India Limited1.27336436853.0009
Domestic EquitiesDr. Reddy's Laboratories Limited1.1620215582.7385
Domestic EquitiesOrchid Pharma Limited1.1391362582.6845
Domestic EquitiesShilpa Medicare Limited1.1312300132.6659
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.060979062.5004
Domestic EquitiesOnesource Specialty Pharma Limited1.0492125272.4728
Domestic EquitiesNavin Fluorine International Limited1.048048932.4699
Domestic EquitiesSupriya Lifescience Limited1.0329368152.4344
Domestic EquitiesStrides Pharma Science Limited1.0212275332.4067
Domestic EquitiesCipla Limited1.0171154192.3970
Domestic EquitiesIPCA Laboratories Limited0.9831157202.3170
Domestic EquitiesSRF Limited0.968475062.2824
Domestic EquitiesCaplin Point Laboratories Limited0.9681110412.2815
Domestic EquitiesLinde India Limited0.874431352.0608
Domestic EquitiesStandard Glass Lining Technology Ltd0.83741064641.9736
Domestic EquitiesSai Life Sciences Limited0.7740225641.8242
Domestic EquitiesAdvanced Enzyme Technologies Limited0.7615511751.7947
Domestic EquitiesBiocon Limited0.7355442841.7333
Domestic EquitiesSBI Life Insurance Company Limited0.732793811.7268
Domestic EquitiesGlenmark Pharmaceuticals Limited0.724480001.7073
Domestic EquitiesUPL Limited0.6931232091.6334
Domestic EquitiesSyngene International Limited0.5199171591.2252
Domestic EquitiesTTK Healthcare Limited0.305557880.7201
Total 98.7118 232.6404
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)1.2882 3.0361
Total 1.2882 3.0361
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.